US Stock MarketDetailed Quotes

CABA Cabaletta Bio

Watchlist
  • 2.290
  • -0.200-8.03%
Close Dec 27 16:00 ET
  • 2.410
  • +0.120+5.24%
Post 20:01 ET
111.93MMarket Cap-1.06P/E (TTM)

Cabaletta Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-61.24%-20.32M
-74.86%-20.79M
-90.26%-23.99M
-15.46%-53.55M
-35.59%-16.45M
-27.13%-12.6M
-3.15%-11.89M
1.57%-12.61M
-35.98%-46.38M
-15.37%-12.13M
Net income from continuing operations
-86.22%-30.63M
-90.53%-27.6M
-57.99%-25.05M
-27.75%-67.68M
-33.10%-20.89M
-43.94%-16.45M
-12.22%-14.49M
-22.46%-15.85M
-14.44%-52.98M
-12.99%-15.69M
Depreciation and amortization
19.44%424K
15.14%426K
7.67%393K
21.05%1.43M
-6.15%336K
-2.20%355K
55.46%370K
66.67%365K
60.71%1.18M
52.99%358K
Other non cash items
241.03%2M
251.35%1.96M
191.73%1.62M
-18.54%2.48M
--780K
--585K
--557K
--556K
--3.04M
----
Change In working capital
428.83%2.9M
96.77%-31K
-2,808.45%-4.13M
102.35%101K
147.70%654K
204.18%548K
-72.17%-959K
92.30%-142K
-177.03%-4.3M
-189.14%-1.37M
-Change in prepaid assets
197.24%528K
-6.36%604K
-198.99%-394K
-3,081.25%-954K
-20,671.43%-1.45M
-59.24%-543K
124.74%645K
327.96%398K
-98.75%32K
99.04%-7K
-Change in payables and accrued expense
126.26%4.44M
123.31%217K
-4,067.39%-1.83M
483.76%4.66M
151.69%3.58M
525.38%1.96M
-7.75%-931K
103.51%46K
-139.32%-1.21M
-38.09%1.42M
-Change in other current assets
23.33%-230K
211.54%116K
-4,018.75%-659K
-450.00%-1.14M
-683.87%-724K
-208.70%-300K
-620.00%-104K
97.45%-16K
-258.62%-208K
475.76%124K
-Change in other current liabilities
-222.28%-1.84M
-70.12%-968K
-119.65%-1.25M
15.60%-2.46M
74.33%-747K
---570K
---569K
---570K
---2.91M
---2.91M
Cash from discontinued investing activities
Operating cash flow
-61.24%-20.32M
-74.86%-20.79M
-90.26%-23.99M
-15.46%-53.55M
-35.59%-16.45M
-27.13%-12.6M
-3.15%-11.89M
1.57%-12.61M
-35.98%-46.38M
-15.37%-12.13M
Investing cash flow
Cash flow from continuing investing activities
18,941.54%12.25M
149.29%23.73M
-103.30%-812K
17.51%-22.45M
459.49%1.14M
-100.27%-65K
-5,261.02%-48.14M
149.33%24.62M
-553.69%-27.22M
-137.22%-316K
Net PPE purchase and sale
-289.23%-253K
-1,250.88%-770K
-113.68%-812K
71.99%-687K
41.46%-185K
94.05%-65K
93.65%-57K
-158.50%-380K
-110.38%-2.45M
-109.27%-316K
Net investment purchase and sale
--12.5M
150.95%24.5M
--0
12.11%-21.76M
--1.32M
--0
---48.09M
150.24%25M
-445.62%-24.76M
--0
Cash from discontinued investing activities
Investing cash flow
18,941.54%12.25M
149.29%23.73M
-103.30%-812K
17.51%-22.45M
459.49%1.14M
-100.27%-65K
-5,261.02%-48.14M
149.33%24.62M
-553.69%-27.22M
-137.22%-316K
Financing cash flow
Cash flow from continuing financing activities
-27.55%71K
-99.60%379K
2,933.19%6.86M
468.89%187.63M
182.90%93.05M
98K
235,545.00%94.26M
343.14%226K
-32.56%32.98M
141.35%32.89M
Net common stock issuance
--0
--0
2,576.72%5.75M
463.70%185.2M
179.22%91.74M
---141K
--93.84M
---232K
-31.91%32.86M
142.60%32.86M
Proceeds from stock option exercised by employees
-70.29%71K
-10.19%379K
142.14%1.11M
1,812.60%2.43M
3,538.89%1.31M
--239K
955.00%422K
798.04%458K
-80.46%127K
-57.65%36K
Cash from discontinued financing activities
Financing cash flow
-27.55%71K
-99.60%379K
2,933.19%6.86M
468.89%187.63M
182.90%93.05M
--98K
235,545.00%94.26M
343.14%226K
-32.56%32.98M
141.35%32.89M
Net cash flow
Beginning cash position
39.46%178.61M
86.79%175.29M
136.79%193.24M
-33.23%81.61M
88.84%115.5M
171.52%128.07M
57.58%93.85M
-33.23%81.61M
20.50%122.22M
-48.28%61.16M
Current changes in cash
36.32%-8.01M
-90.30%3.32M
-246.63%-17.95M
374.85%111.63M
280.24%77.74M
-189.83%-12.57M
376.38%34.23M
119.53%12.24M
-295.33%-40.62M
416.00%20.44M
End cash Position
47.71%170.61M
39.46%178.61M
86.79%175.29M
136.79%193.24M
136.79%193.24M
88.84%115.5M
171.52%128.07M
57.58%93.85M
-33.23%81.61M
-33.23%81.61M
Free cash flow
-62.41%-20.58M
-80.47%-21.56M
-90.95%-24.8M
-11.06%-54.24M
-33.63%-16.63M
-15.11%-12.67M
3.85%-11.95M
-0.25%-12.99M
-38.44%-48.83M
-16.70%-12.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -61.24%-20.32M-74.86%-20.79M-90.26%-23.99M-15.46%-53.55M-35.59%-16.45M-27.13%-12.6M-3.15%-11.89M1.57%-12.61M-35.98%-46.38M-15.37%-12.13M
Net income from continuing operations -86.22%-30.63M-90.53%-27.6M-57.99%-25.05M-27.75%-67.68M-33.10%-20.89M-43.94%-16.45M-12.22%-14.49M-22.46%-15.85M-14.44%-52.98M-12.99%-15.69M
Depreciation and amortization 19.44%424K15.14%426K7.67%393K21.05%1.43M-6.15%336K-2.20%355K55.46%370K66.67%365K60.71%1.18M52.99%358K
Other non cash items 241.03%2M251.35%1.96M191.73%1.62M-18.54%2.48M--780K--585K--557K--556K--3.04M----
Change In working capital 428.83%2.9M96.77%-31K-2,808.45%-4.13M102.35%101K147.70%654K204.18%548K-72.17%-959K92.30%-142K-177.03%-4.3M-189.14%-1.37M
-Change in prepaid assets 197.24%528K-6.36%604K-198.99%-394K-3,081.25%-954K-20,671.43%-1.45M-59.24%-543K124.74%645K327.96%398K-98.75%32K99.04%-7K
-Change in payables and accrued expense 126.26%4.44M123.31%217K-4,067.39%-1.83M483.76%4.66M151.69%3.58M525.38%1.96M-7.75%-931K103.51%46K-139.32%-1.21M-38.09%1.42M
-Change in other current assets 23.33%-230K211.54%116K-4,018.75%-659K-450.00%-1.14M-683.87%-724K-208.70%-300K-620.00%-104K97.45%-16K-258.62%-208K475.76%124K
-Change in other current liabilities -222.28%-1.84M-70.12%-968K-119.65%-1.25M15.60%-2.46M74.33%-747K---570K---569K---570K---2.91M---2.91M
Cash from discontinued investing activities
Operating cash flow -61.24%-20.32M-74.86%-20.79M-90.26%-23.99M-15.46%-53.55M-35.59%-16.45M-27.13%-12.6M-3.15%-11.89M1.57%-12.61M-35.98%-46.38M-15.37%-12.13M
Investing cash flow
Cash flow from continuing investing activities 18,941.54%12.25M149.29%23.73M-103.30%-812K17.51%-22.45M459.49%1.14M-100.27%-65K-5,261.02%-48.14M149.33%24.62M-553.69%-27.22M-137.22%-316K
Net PPE purchase and sale -289.23%-253K-1,250.88%-770K-113.68%-812K71.99%-687K41.46%-185K94.05%-65K93.65%-57K-158.50%-380K-110.38%-2.45M-109.27%-316K
Net investment purchase and sale --12.5M150.95%24.5M--012.11%-21.76M--1.32M--0---48.09M150.24%25M-445.62%-24.76M--0
Cash from discontinued investing activities
Investing cash flow 18,941.54%12.25M149.29%23.73M-103.30%-812K17.51%-22.45M459.49%1.14M-100.27%-65K-5,261.02%-48.14M149.33%24.62M-553.69%-27.22M-137.22%-316K
Financing cash flow
Cash flow from continuing financing activities -27.55%71K-99.60%379K2,933.19%6.86M468.89%187.63M182.90%93.05M98K235,545.00%94.26M343.14%226K-32.56%32.98M141.35%32.89M
Net common stock issuance --0--02,576.72%5.75M463.70%185.2M179.22%91.74M---141K--93.84M---232K-31.91%32.86M142.60%32.86M
Proceeds from stock option exercised by employees -70.29%71K-10.19%379K142.14%1.11M1,812.60%2.43M3,538.89%1.31M--239K955.00%422K798.04%458K-80.46%127K-57.65%36K
Cash from discontinued financing activities
Financing cash flow -27.55%71K-99.60%379K2,933.19%6.86M468.89%187.63M182.90%93.05M--98K235,545.00%94.26M343.14%226K-32.56%32.98M141.35%32.89M
Net cash flow
Beginning cash position 39.46%178.61M86.79%175.29M136.79%193.24M-33.23%81.61M88.84%115.5M171.52%128.07M57.58%93.85M-33.23%81.61M20.50%122.22M-48.28%61.16M
Current changes in cash 36.32%-8.01M-90.30%3.32M-246.63%-17.95M374.85%111.63M280.24%77.74M-189.83%-12.57M376.38%34.23M119.53%12.24M-295.33%-40.62M416.00%20.44M
End cash Position 47.71%170.61M39.46%178.61M86.79%175.29M136.79%193.24M136.79%193.24M88.84%115.5M171.52%128.07M57.58%93.85M-33.23%81.61M-33.23%81.61M
Free cash flow -62.41%-20.58M-80.47%-21.56M-90.95%-24.8M-11.06%-54.24M-33.63%-16.63M-15.11%-12.67M3.85%-11.95M-0.25%-12.99M-38.44%-48.83M-16.70%-12.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List